Cargando…

Rapid Diagnosis Of Multidrug-Resistant Tuberculosis Impacts Expenditures Prior To Appropriate Treatment: A Performance And Diagnostic Cost Analysis

BACKGROUND: In this study, we aimed to describe the impact of the Genotype® MTBDRplus line probe assay (LPA) for multidrug-resistant tuberculosis (MDR-TB) on total costs in a high-burden setting in China. The second objective was to evaluate the performance of HAIN on smear-positive sputum and clini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xuezheng, Deng, Yunfeng, Wang, Junling, Jing, Hui, Shu, Wei, Qin, Jingmin, Pang, Yu, Ma, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861515/ https://www.ncbi.nlm.nih.gov/pubmed/31814743 http://dx.doi.org/10.2147/IDR.S224518

Ejemplares similares

Expenditure in Excess of Appropriations
Publicado: (1958)

Expenditure in Excess of Appropriations
Publicado: (1959)

Expenditure in Excess of Appropriations
Publicado: (1957)

Expenditure in Excess of Appropriations
Publicado: (1957)

Expenditure in Excess of Appropriations
Publicado: (1963)

Expenditure in Excess of Appropriations
Publicado: (1964)

Expenditure in Excess of Appropriations
Publicado: (1960)

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016)

Transfers and Expenditure in Excess of Appropriations
Publicado: (1962)

Transfers and Expenditure in Excess of Appropriations
Publicado: (1961)

Cost analysis of rapid diagnostics for drug-resistant tuberculosis
por: Groessl, Erik J., et al.
Publicado: (2018)

Disparity and Convergence: Chinese Provincial Government Health Expenditures
por: Pan, Jay, et al.
Publicado: (2013)

Cost-effectiveness analysis of malaria rapid diagnostic tests for appropriate treatment of malaria at the community level in Uganda
por: Hansen, Kristian S, et al.
Publicado: (2017)

Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis
por: Resch, Stephen C, et al.
Publicado: (2006)

Time to appropriate treatment in patients with multidrug-resistant tuberculosis in South Korea: Are we still in 2010?
por: Jo, Eun-Jung, et al.
Publicado: (2019)

Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using a MGIT 960 System
por: Koh, Won-Jung, et al.
Publicado: (2012)

Trends in Medical Expenditures Prior to Diabetes Diagnosis: The Early Burden of Diabetes
por: Khan, Tamkeen, et al.
Publicado: (2021)

Pathways to multidrug-resistant tuberculosis diagnosis and treatment initiation: a qualitative comparison of patients’ experiences in the era of rapid molecular diagnostic tests
por: Naidoo, Pren, et al.
Publicado: (2015)

Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update
por: Diel, Roland, et al.
Publicado: (2020)

1881. Costs of Treating Multidrug Resistant Tuberculosis in California, 2022
por: Katrak, Shereen, et al.
Publicado: (2023)

Diagnostic pathways and direct medical costs incurred by new adult pulmonary tuberculosis patients prior to anti-tuberculosis treatment – Tamil Nadu, India
por: Veesa, Karun Sandeep, et al.
Publicado: (2018)

Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosis
por: Scherer, Luciene C, et al.
Publicado: (2009)

Diagnosis and treatment of multidrug-resistant tuberculosis
por: Jang, Jong Geol, et al.
Publicado: (2020)

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017)

A simple, rapid and economic method for detecting multidrug-resistant tuberculosis
por: Wang, Xia, et al.
Publicado: (2013)

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
por: Weerasuriya, Chathika K, et al.
Publicado: (2021)

Appropriateness of laboratory expenditure for primary health care facilities across South Africa
por: Mahomed, Ozayr, et al.
Publicado: (2023)

Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa
por: Shah, Maunank, et al.
Publicado: (2013)

Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Sputum microbiota as a potential diagnostic marker for multidrug-resistant tuberculosis
por: Lin, Dongzi, et al.
Publicado: (2021)

Laboratory Cost Analysis of Conventional and Newer Molecular Tests for Diagnosis of Presumptive Multidrug-Resistant Tuberculosis Patients
por: Yadav, Raj Narayan, et al.
Publicado: (2022)

Cost-Effectiveness Comparison of Genechip and Conventional Drug Susceptibility Test for Detecting Multidrug-Resistant Tuberculosis in China
por: Pang, Yu, et al.
Publicado: (2013)

An Integrated Approach to Rapid Diagnosis of Tuberculosis and Multidrug Resistance Using Liquid Culture and Molecular Methods in Russia
por: Balabanova, Yanina, et al.
Publicado: (2009)

Isolation measures and protection awareness are significant for latent tuberculosis infection: a cross-sectional study based on T-SPOT.TB among health care workers in China
por: Deng, Yunfeng, et al.
Publicado: (2019)

The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia
por: Miller, Thaddeus L, et al.
Publicado: (2013)

Correction to: The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug-resistant tuberculosis in India and China
por: Weerasuriya, Chathika K., et al.
Publicado: (2022)

Direct sequencing for rapid detection of multidrug resistant Mycobacterium tuberculosis strains in Morocco
por: Zakham, Fathiah, et al.
Publicado: (2013)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Rapid and Accurate Diagnosis of Pediatric Tuberculosis Disease: A Diagnostic Accuracy Study for Pediatric Tuberculosis
por: Olbrich, Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_95fq533c9at14ejqk4ed75rug7